Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford Medical Alumni Network

Sign up for mailings - keep in touch with medicine at Oxford.

Update your detailsMake sure you receive alumni news and event invitations.

Medical Sciences Division News

12 Oxford scientists elected Fellows of the Royal Society

Twelve renowned Oxford researchers have been elected Fellows of the Royal Society, the UK’s national academy of sciences, in recognition of their exceptional contributions to advancing scientific knowledge.

Expert comment: landmark plans to accelerate rare disease treatments in the UK are a welcome development

Matthew Wood, Professor of Neuroscience in the Department of Paediatrics at the University of Oxford and Director & Chief Scientific Officer of the Oxford-Harrington Rare Disease Centre, comments on new government plans to bring treatments for rare diseases a step closer.

Academy of Medical Sciences elects five Oxford researchers as new Fellows

The Academy of Medical Sciences has elected five University of Oxford biomedical and health scientists to its fellowship in 2026.

Expert Comment: the hidden mental health impacts of heatwaves

Ahead of the forecast high temperatures over the UK’s Spring Bank Holiday weekend, Dr Laurence Wainwright, Senior Departmental Lecturer at the Smith School of Enterprise & Environment and Senior Researcher in the Department of Psychiatry, outlines the unexpected risks.

Statement on vaccine efforts relating to the Bundibugyo Ebolavirus outbreak in the Democratic Republic of the Congo

In response to the current Bundibugyo Ebolavirus outbreak in the Democratic Republic of the Congo, the Oxford Vaccine Group (OVG) is working urgently with Oxford’s own Clinical BioManufacturing Facility and the Serum Institute of India Pvt. Ltd. (SIIPL), to rapidly produce and scale doses of our ChAdOx-based monovalent Bundibugyo Ebolavirus candidate vaccine, ChAdOx1 BDBV.